All Stories

  1. A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation
  2. Mediators of Antenatal Inflammation Propagating Chronic Neonatal Lung Disease
  3. The IL-33/ST2-axis Contributes to the Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension
  4. Altered hepatic and intestinal homeostasis in a neonatal murine model of short-term total parenteral nutrition and antibiotics
  5. Antimicrobial peptides modulate lung injury by altering the intestinal microbiota
  6. Clinical trial of a probiotic and herbal supplement for lung health
  7. The fungal intestinal microbiota predict the development of bronchopulmonary dysplasia in very low birthweight newborns
  8. Clinical Trial of a Probiotic and Herbal Supplement for Lung and Gut Health
  9. Impact of total parenteral nutrition and antibiotics on hepatic and intestinal homeostasis in pediatric murine model
  10. The Fungal Intestinal Microbiota Predict the Development of Bronchopulmonary Dysplasia in Very Low Birthweight Newborns
  11. Antimicrobial peptides modulate lung injury by altering the intestinal microbiota
  12. Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics
  13. Association of mycoplasma and ureaplasma respiratory colonization and bronchopulmonary dysplasia in extremely preterm infants- a propensity score matched case-control study
  14. Clinical Trial of a Probiotic and Herbal Supplement for Lung and Gut Health
  15. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation
  16. Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation
  17. Reply to Pantaleón García et al.
  18. Hyperoxia Exposure Produces Indirect Lung Injury by Altering Antimicrobial Peptide Production and the Microbiota of the Newborn Small Intestine
  19. Sa1655: PROBIOTIC AND HERBAL BLEND DECREASES MARKERS OF NEUTROPHILIC INFLAMMATION IN IN VITRO AND IN VIVO MODELS OF PROTEOBACTERIA-INDUCED DYSBIOSIS
  20. Dietary Lipid Oxidization Products Alter Growth, Adiposity and Gut Microbial Ecology in Prepubertal Porcine Model
  21. The gut microbiome of extremely preterm infants randomized to the early progression of enteral feeding
  22. Necrotizing enterocolitis and the gut-lung axis
  23. Hyperoxia Exposure in Neonatal Period Is Associated with Decrease in HB-EGF Expression in Mice Kidneys
  24. Toll-like receptors: shapers of the pulmonary microbiome?
  25. Chorioamnionitis and neonatal outcomes
  26. The Fungal Airway Mycobiome Predicts the Development of Bronchopulmonary Dysplasia
  27. The gut mycobiome influences the host's metabolism of processed food
  28. Recent advances in understanding the ecology of the lung microbiota and deciphering the gut-lung axis
  29. The closed eye harbours a unique microbiome in dry eye disease
  30. The gut mycobiome of healthy mice is shaped by the environment and shapes metabolic outcomes in response to diet
  31. A stable cutaneous mycobiome exists from birth
  32. Fungal Airway Microbiome at Birth
  33. Variability in interkingdom gut microbiomes between different commercial vendors shapes fat gain in response to diet
  34. TGR5 signaling mitigates parenteral nutrition-associated liver disease
  35. Mice without a microbiome are partially protected from lung injury by hyperoxia
  36. The closed eye harbors a unique microbiome in dry eye disease
  37. 1174: IL-6 Knockout decreases severity of lung injury in an experimental model of bronchopulmonary dysplasia (BPD)
  38. 188: Absence of IL-6 does not decrease pulmonary inflammation in two models of bronchopulmonary dysplasia (BPD)
  39. Maternal Antibiotic Treatment May Harm Preemies’ Lungs
  40. Babies are born with fungi in their guts
  41. Maternal Peripartum Antibiotic Exposure Worsens Experimental Bronchopulmonary Dysplasia
  42. Fungi form interkingdom microbial communities in the primordial human gut that develop with gestational age
  43. The human primordial microbiome hosts complex bacterial and fungal interkingdom ecologies that vary with gestational age
  44. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia
  45. The death knell of inhaled nitric oxide to prevent bronchopulmonary dysplasia?
  46. Shaken or Stirred? Evaluating the combination of budesonide-surfactant for survival free of bronchopulmonary dysplasia
  47. Bariatric Surgery and the Pregnancy Complicated by Gestational Diabetes
  48. Pregnancy and neonatal outcome after bariatric surgery
  49. Bariatric surgery and pregnancy: the magical solution?
  50. Bariatric Surgery: Impact on Pregnancy Outcomes